# JNL/Mellon Healthcare Sector Fund

JNL/Mellon Healthcare Sector Fund is a registered fund series of JNL Series Trust (series S000068125). Net assets $2.6B as of 2026-03-31. Index fund.

## Profile

- Series ID: S000068125
- Registrant: JNL Series Trust
- LEI: 54930024HJBJ7HNLBO26
- Net assets: $2.6B
- Total assets: $2.6B
- As of: 2026-03-31
- Type: Index

## Advisers

- [Mellon Investments Corporation (Subadvisor)](https://search.stillhousedata.com/firm/105764)
- [Jackson National Asset Management, LLC (Advisor)](https://search.stillhousedata.com/firm/111079)

## Top holdings (135 reported)

_Showing 15 of 135 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| [Eli Lilly and Company](https://search.stillhousedata.com/security/532457108) | — | $313.8M | 1229.75% |
| [Johnson & Johnson](https://search.stillhousedata.com/security/478160104) | — | $252.2M | 988.32% |
| [AbbVie Inc.](https://search.stillhousedata.com/security/00287Y109) | — | $164.6M | 644.93% |
| [Merck & Co., Inc.](https://search.stillhousedata.com/security/58933Y105) | — | $128.0M | 501.46% |
| [UnitedHealth Group Incorporated](https://search.stillhousedata.com/security/91324P102) | — | $105.1M | 411.86% |
| [Amgen Inc.](https://search.stillhousedata.com/security/031162100) | — | $81.1M | 317.66% |
| [Thermo Fisher Scientific Inc.](https://search.stillhousedata.com/security/883556102) | — | $79.1M | 310.17% |
| [Abbott Laboratories](https://search.stillhousedata.com/security/002824100) | — | $76.5M | 299.83% |
| [Gilead Sciences, Inc.](https://search.stillhousedata.com/security/375558103) | — | $74.1M | 290.42% |
| [Intuitive Surgical, Inc.](https://search.stillhousedata.com/security/46120E602) | — | $69.7M | 273.10% |
| [Pfizer Inc.](https://search.stillhousedata.com/security/717081103) | — | $68.2M | 267.27% |
| [Bristol-Myers Squibb Company](https://search.stillhousedata.com/security/110122108) | BMY | $52.9M | 207.27% |
| [Danaher Corporation](https://search.stillhousedata.com/security/235851102) | — | $52.3M | 205.14% |
| [Stryker Corporation](https://search.stillhousedata.com/security/863667101) | — | $50.9M | 199.43% |
| [Vertex Pharmaceuticals Incorporated](https://search.stillhousedata.com/security/92532F100) | — | $48.5M | 190.10% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-03-31 | $2.6B |
| 2025-12-31 | $2.8B |
| 2025-09-30 | $2.7B |
| 2025-06-30 | $2.7B |
| 2025-03-31 | $3.0B |
| 2024-12-31 | $2.9B |
| 2024-09-30 | $3.4B |
| 2024-06-30 | $3.3B |

## More

- [Registrant: JNL Series Trust](https://search.stillhousedata.com/registrant/933691)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000068125.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.